Modulating effect of DL-kavain on the mutagenicity and carcinogenicity induced by doxorubicin in Drosophila melanogaster

References

• Abraham, S. K. 1994. Antigenotoxicity of coffee in the Drosophila assay for somatic mutation and recombination. Mutagenesis 9:383–86. doi:10.1093/mutage/9.4.383.
   PubMed Web of Science ®Google Scholar
• Adesola, R. O., J. T. Lawal, and O. E. Oladele. 2021. Drosophila melanogaster (Meigen, 1830): A potential model for human diseases. World News Nat. Sci. Int. Sci. J 36:42–59.
   Google Scholar
• Alaraby, M., B. Annangi, R. Marcos, and A. Hernandez. 2016. Drosophila melanogaster as a suitable in vivo model to determine potential side effects of nanomaterials: A review. J Toxicol Environ Health B 19:65–104. doi:10.1080/10937404.2016.1166466.
   PubMed Web of Science ®Google Scholar
• Amorim, É. M., S. L. Santana, A. S. Silva, N. C. Aquino, E. R. Silveira, R. M. Ximenes, and C. Rohde. 2019. Genotoxic assessment of the dry decoction of Myracrodruon urundeuva Allemão (Anacardiaceae) leaves in somatic cells of Drosophila melanogaster by the comet and SMART Assays. Environ. Mol. Mutagen. doi:10.1002/em.22332.
   PubMed Web of Science ®Google Scholar
• Anke, J., and I. Ramzan. 2004. Pharmacokinetic and pharmacodynamic drug interactions with Kava (Piper methysticum Forst f. J. Ethnopharmacol 93:153–60. doi:10.1016/j.jep.2004.04.009.
   PubMed Web of Science ®Google Scholar
• Antunes, L. M. G., and C. S. Takahashi. 1998. Effects of high doses of vitamins C and E against doxorrubicin – Induced chomosomal damage in Wistar rat bone marrow cells. Mutat. Res./Genet. Toxicol. Environ. Mutagen 419:137–43. doi:10.1016/S1383-5718(98)00134-X.
   PubMed Web of Science ®Google Scholar
• Aporosa, S. A., M. Atkins, and J. N. Leov. 2021. Decolonising quantitative methods within a Pacific research space to explore cognitive effects following kava use. J. Interdiscip. Res 5:74–92. doi:10.26021/10642.
   Google Scholar
• Baldridge, D., M. F. Wangler, A. N. Bowman, S. Yamamoto, T. Schedl, S. C. Pak, J. H. Postlethwait, J. Shin, L. Solnica-Krezel, H. J. Bellen, et al.. 2021. Model organisms contribute to diagnosis and discovery in the undiagnosed diseases network: Current state and a future vision. Orphanet J. Rare Dis 16:206. doi:10.1186/s13023-021-01839-9.
   PubMed Web of Science ®Google Scholar
• Bale, A. S., E. Kenyon, T. J. Flynn, J. C. Lipscomb, D. L. Mendrick, T. Hartung, and G. W. Patton. 2014. Correlating in vitro data to in vivo find for risk assessment. Altern. Animal Exp 31:79–90. doi:10.14573/altex.1310011.
   Web of Science ®Google Scholar
• Bian, T., P. Corral, Y. Wang, J. Botello, R. Kingston, T. Daniels, R. G. Salloum, E. Johnston, Z. Huo, J. Lu, et al.. 2020. Kava as a clinical nutrient: Promises and challenges. Nutrients 12:3044. doi:10.3390/nu12103044..
   PubMed Web of Science ®Google Scholar
• Bisneto, A. V. M., L. C. Oliveira, A. S. Fernandes, L. S. Silva, J. H. Veras, C. G. Cardoso, C. R. Silva, A. V. M. Filho, C. C. Carneiro, and -C.-C. Lee. 2021. Recombinogenic, genotoxic and cytotoxic effects of azathioprine using in vivo assays. J. Toxicol. Saúde Ambient. Parte A 84:261–71. doi:10.1080/15287394.2020.1864692.
   Google Scholar
• Carmona, E. R., M. Reyes-Díaz, J. Parodi, and C. Inostroza-Blancheteau. 2017. Antimutagenic evaluation of traditional medicinal plants from South America Peumus boldus and Cryptocarya alba using Drosophila melanogaster. J Toxicol Environ Health A. 80:208–17. doi:10.1080/15287394.2017.1279574.
   PubMed Web of Science ®Google Scholar
• Celentano, A., C. Yiannis, R. Paolini, P. Zhang, C. S. Farah, N. Cirillo, T. Yap, and M. McCullough. 2020. Kava constituents exert selective anticancer effects in oral squamous cell carcinoma cells in vitro. Sci. Rep. 10:15904. doi:10.1038/s41598-020-73058-4.
   PubMed Web of Science ®Google Scholar
• Chahine, N., and R. Chahine. 2020. Protecting mechanisms of saffron extract against doxorubicin toxicity in ischemic heart. Saffron 12:141–54. doi:10.1016/b978-0-12-818462-2.00012-7.
   Google Scholar
• Chua, H. C., E. T. H. Christensen, K. H. Jesen, L. Y. Hartiadi, I. Ramzan, A. A. Jesen, N. L. Absalom, and M. Chebib. 2016. Kavain, the major constituent of the anxiolytic kava extract, potentiates GABAA receptors: Functional characteristics and molecular mechanism. PLoS ONE 11:e0157700. doi:10.1371/journal.pone.0157700.
   PubMed Web of Science ®Google Scholar
• Costa, W. F., and J. C. Nepomuceno. 2006. Protective effects of a mixture of antioxidant vitamins and mineral on the genotoxicity of doxorubicin in somatic cells of Drosophila melanogaster. Environ. Mol. Mutagen. 47:18–24. doi:10.1002/em.20160.
   PubMed Web of Science ®Google Scholar
• De Rezende, A. A. A., C. C. Munari, P. F. Oliveira, N. H. Ferreira, D. C. Tavares, S. M. L. Andrade, N. H. Rezende, and M. A. A. Spanó. 2013. A comparative study of the modulatory effects of (−)-cubebin on the mutagenicity/recombinogenicity induced by different chemical agents. Food Chem. Toxicol 55:645–52. doi:10.1016/j.fct.2013.01.050.
   PubMed Web of Science ®Google Scholar
• De Rezende, A. A. A., M. L. A. Silva, D. C. Tavares, W. R. Cunha, K. C. S. Rezende, J. K. Bastos, M. A. Spanó, H. H. R. de Andrade, Z. R. Guterres, and L. P. Silva. 2011. The effect of the dibenzylbutyrolactoliclignan (-)-cubebin on doxorubicin mutagenicity and recombinogenicity in wing somatic cells of . Drosophila Melanogaster. Food Chem. Toxicol 49:1235–41. doi:10.1016/j.fct.2011.03.001.
   PubMed Web of Science ®Google Scholar
• Ertuğrul, H., B. Yalçın, M. Güneş, and B. Kaya. 2019. Ameliorative effects of melatonin against nano and ionic cobalt induced genotoxicity in two in vivo Drosophila assays. Drug Chem. Toxicol 43:279–86. doi:10.1080/01480545.2019.1585444.
   PubMed Web of Science ®Google Scholar
• Ferreira, J. V., A. V. Braga, R. R. Machado, D. Michel, G. A. Pianetti, A. El-Aneed, and I. C. César. 2019. Liquid chromatography-tandem mass spectrometry bioanalytical method for the determination of kavain in mice plasma: Application to a pharmacokinetic study. J. Chromatogr. B 1137:121939. doi:10.1016/j.jchromb.2019.121939.
   PubMed Web of Science ®Google Scholar
• Frei, H., and F. E. Würgler. 1988. Statistical methods to decide whether mutagenicity test data from Drosophila assay indicate a positive, negative, or inconclusive result. Mutat. Res./Genet. Toxicol. Environ. Mutagen 203:297–308. doi:10.1016/0165-1161(88)90019-2.
   PubMed Web of Science ®Google Scholar
• Frei, H., and F. E. Würgler. 1995. Optimal experimental design and sample size for the evaluation of data from somatic mutation and recombination test (SMART). In Drosophila. Mutat. Res./Genet. Toxicol. Environ. Mutagen 334:247–58. doi:10.1016/0165-1161(95)90018-7.
   PubMed Web of Science ®Google Scholar
• Freitas, K. S., . I. S., N. Squarisi, H. D. O Acésio, S. D. Nicolella, M. R. S. Ozelin, A. P. P. Melo, G. Guissone, L. M. Fernandes, A. A. S. Silva, A. V. M. Filho, et al.. 2020. Licochalcone A, a licorice flavonoid: Antioxidant, cytotoxic, genotoxic, and chemopreventive potential. J. Toxicol. Environ. Health A 83:673–86. doi:10.1080/15287394.2020.1813228.
   PubMed Web of Science ®Google Scholar
• Frölich, A., and F. E. Würgler. 1989. New tester strains with improved bioactivation capacity for the Drosophila wing-spot test. Mutat. Res./Genet. Toxicol. Environ. Mutagen 216:179–87. doi:10.1016/0165-1161(89)90003-4.
   PubMedGoogle Scholar
• Gleitz, J., A. Beile, P. Wilkens, A. Ameri, and T. Peters. 1997. Antithrombotic action of the kava pyrone (+)-kavain prepared from Piper methysticum on human platelets. Planta Med. 63:27–30. doi:10.1055/s-2006-957597.
   PubMed Web of Science ®Google Scholar
• Gleitz, J., J. Friese, A. Beile, A. Ameri, and T. Peters. 1996. Anticonvulsive action of (±)-kavain estimated from its properties on stimulated synaptosomes and Na+ channel receptor sites. Eur. J. Pharmacol 315:89–97. doi:10.1016/S0014-2999(96)00550-X.
   PubMed Web of Science ®Google Scholar
• Graf, U., and F. E. Würgler. 1996. The somatic white-ivory eye spot test does not detect the same spectrum of genotoxic events as the wing somatic mutation and recombination test in Drosophila melanogaster. Environ. Mol. Mutagen 27:219–26. doi:10.1002/(SICI)1098-2280(1996)27:3<219::AID-EM7>3.0.CO;2-9.
   PubMed Web of Science ®Google Scholar
• Graf, U., F. E. Würgler, A. J. Katz, H. Frei, H. Juon, C. B. Hall, and P. G. Kale. 1984. Somatic mutation and recombination test in Drosophila melanogaster. Environ. Mutagen. 6:153–88. doi:10.1002/em.2860060206.
   PubMedGoogle Scholar
• Graf, U., and N. Schaik. 1992. Improved high bioactivation cross for the wing somatic mutation and recombination test in Drosophila melanogaster. Mutat. Res. Environ. Mutagen. Relat. Subj 271:59–67. doi:10.1016/0165-1161(92)90032-H.
   PubMed Web of Science ®Google Scholar
• Grunze, H., J. Langosch, K. Schirrmacher, D. Bingmann, J. Von Wegerer, and J. Walden. 2001. Kava pyrones exert effects on neuronal transmission and transmembraneous cation currents similar to established mood stabilizers - a review. Prog. Neuro-Psychopharmacol. Biol. Psychiat 25:1555–70. doi:10.1016/S0278-5846(01)00208-1.
   PubMed Web of Science ®Google Scholar
• Guerra-Santos, I. J., J. D. Rocha, C. R. Vale, W. C. Sousa, A. M. Teles, L. Chen-Chen, S. Carvalho, and E. F. L. C. Bailão. 2016. Vernonanthura polyanthes leaves aqueous extract enhances doxorubicin genotoxicity in somatic cells of Drosophila melanogaster and presents no antifungal activity against Candida spp. Braz. J. Biol 76:928–36. doi:10.1590/1519-6984.04615.
   PubMed Web of Science ®Google Scholar
• Keizer, H. G., H. M. Pinedo, G. J. Schuurhuis, and H. Joenje. 1990. Doxorubicin (adriamycin): A critical review of free radical-dependent mechanisms of cytotoxicity. Pharmacol. Ther 47:219–31. doi:10.1016/0163-7258(90)90088-J.
   PubMed Web of Science ®Google Scholar
• Köppel, C., and J. Tenczer. 1991. Mass spectral characterization of urinary metabolites of D,L-kawain. J. Chromatogr. B: Biomed. Sci. Appl 562:207–11. doi:10.1016/0378-4347(91)80578-Z.
   Google Scholar
• Kormann, E. C., P. A. Amaral, M. David, V. L. E. Lima, V. C. Filho, and F. C. Buzzi. 2012. Kavain analogues as potential analgesic agents. Pharmacol. Rep 64:1419–26. doi:10.1016/s1734-1140(12)70939-8.
   PubMed Web of Science ®Google Scholar
• Kuchta, K., M. Schmidt, and A. Nahrstedt. 2015. German kava ban lifted by court: The alleged hepatotoxicity of kava (Piper methysticum) as a case of Ill-defined herbal drug identity, lacking quality control, and misguided regulatory politics. Planta Med. 81:1647–53. doi:10.1055/s-0035-1558295.
   PubMed Web of Science ®Google Scholar
• Lebot, V., J. Kaoh, and L. Legendre. 2020. High-throughput analysis of flavokawains in kava (Piper methysticum Forst. f.) roots, chips and powders and correlations with their acetonic extracts absorbance. Food Anal. Meth 13 (8):1583–93. doi:10.1007/s12161-020-01781-9.
   Web of Science ®Google Scholar
• Lebot, V., and J. Lévesque. 1989. The origin and distribution of kava (Piper Methysticum Forst. F., piperaceae): A phytochemical approach. Allertonia 5:223–81.
   Google Scholar
• Lehmann, M., A. Franco, K. S. P. Vilar, M. L. Reguly, and H. H. R. Andrade. 2003. Doxorubicin and two of its analogues are preferential inducers of homologous recombination compared with mutational events in somatic cells of Drosophila melanogaster. Mutat. Res./Genet. Toxicol. Environ. Mutagen 539:167–75. doi:10.1016/S1383-5718(03)00162-1.
   PubMed Web of Science ®Google Scholar
• Lenz, S. P., J. B. Karsten, Schulz, A. Voigt, and J. B. Schulz. 2013. Drosophila as a screening tool to study human neurodegenerative diseases. J. Neurochem 127:452–60. doi:10.1111/jnc.12446.
   Web of Science ®Google Scholar
• Li, X., Z. Liu, X. Xu, C. A. Blair, Z. Sun, J. Xie, M. B. Lilly, and X. Zi. 2012. Kava components down-regulate expression of AR and AR splice variants and reduce growth in patient derived prostate cancer xenografts in mice. PLoS ONE 7:e31213. doi:10.1371/journal.pone.0031213.
   PubMed Web of Science ®Google Scholar
• Lobo, V., A. Patil, A. Phatak, and N. Chandra. 2010. Free radicals, antioxidants and functional foods: Impact on human health. Pharmacog. Rev 4:118–26. doi:10.4103/0973-7847.70902.
   PubMedGoogle Scholar
• Martin, A. C., E. Johnston, C. Xing, and A. D. Hegeman. 2014. Measuring the chemical and cytotoxic variability of commercially available kava (Piper methysticum G. Forster). PLoS ONE 9:e111572. doi:10.1371/journal.pone.0111572.
   PubMed Web of Science ®Google Scholar
• Mathews, J. M., A. S. Etheridge, J. L. Valentine, S. R. Black, D. P. Coleman, P. Patel, J. So, and L. T. Burka. 2005. Pharmacokinetics and disposition of the kavalactone kawain. Interaction with Kava Extract and Kavalactones in Vivo and in Vitro. Drug Metab. Dispos 33:1555–63. doi:10.1124/dmd.105.004317.
   Google Scholar
• Mathews, J. M., A. S. Etheridge, and S. R. Black. 2002. Inhibition of human Cytochrome P450 activities by kava extract and kavalactones. Drug Metab. Dispos 30:1153–57. doi:10.1124/dmd.30.11.1153.
   PubMed Web of Science ®Google Scholar
• Mattes, W. B. 2020. In vitro to in vivo translation. Curr. Opin. Toxicol 23–24:114–18. doi:10.1016/j.cotox.2020.09.001.
   Web of Science ®Google Scholar
• Meigen, J. W. 1830. Systematische Beschreibung der bekannten europäischen zweiflügeligen Insekten. Schulzische Buchhandlung, Hamm. Vol. 6.
   Google Scholar
• Mirzoyan, Z., M. Sollazzo, M. Allocca, A. M. Valenza, D. Grifoni, and P. Bellosta. 2019. Drosophila melanogaster: A model organism to study cancer. Front. Genet 10:51. doi:10.3389/fgene.2019.00051.
   PubMed Web of Science ®Google Scholar
• Morais, C. R., A. M. Bonetti, S. M. Carvalho, A. A. A. Rezende, G. R. Araujo, and M. A. Spanó. 2016. Assessment of mutagenic, recombinogenic and carcinogenic potential of fipronil insecticide in somatic cells of Drosophila melanogaster. Chemosphere 165:342e351. doi:10.1016/j.chemosphere.2016.09.023.
   Web of Science ®Google Scholar
• Naves, M. P. C., C. R. Morais, A. C. A. Silva, N. O. Dantas, M. A. Spanó, and A. A. A. De Rezende. 2018. Assessment of mutagenic, recombinogenic and carcinogenic potential of titanium dioxide nanocristals in somatic cells of Drosophila melanogaster. Food Chem. Toxicol. 112:273–81. doi:10.1016/j.fct.2017.12.040.
   Web of Science ®Google Scholar
• Neafsey, P., G. Ginsberg, D. Hattis, and B. Sonawane. 2009. Genetic polymorphism in Cytochrome P450 2D6 (CYP2D6): Population distribution of CYP2D6 activity. J. Toxicol. Environ. Health B 12:334–61. doi:10.1080/10937400903158342.
   PubMed Web of Science ®Google Scholar
• Olsen, L., C. Ostenbrink, and F. S. Jorgensen. 2015. Prediction of cytochrome P450 mediated metabolism. Adv. Drug Delivery Rev 86:61–71. doi:10.1016/j.addr.2015.04.020.
   PubMed Web of Science ®Google Scholar
• Ooi, S. L., P. Henderson, and S. C. Pak. 2018. Kava for generalized anxiety disorder: A review of current evidence. J. Altern. Complemento. Med 24:770–80. doi:10.1089/acm.2018.0001.
   PubMed Web of Science ®Google Scholar
• Orsolin, P. C., R. G. S. Oliveira, and J. C. Nepomuceno. 2012. Assessment of the mutagenic, recombinagenic and carcinogenic potential of orlistat in somatic cells of Drosophila melanogaster. Food Chem. Toxicol. 50:2598–604. doi:10.1016/j.fct.2012.05.008.
   Web of Science ®Google Scholar
• Oshima-Franco, Y., and L. M. Franco. 2003. Biotransformação: Importância e toxicidade. Saúde Em Rev 5:69–76.
   Google Scholar
• Pandey, U. B., and C. D. Nichols. 2011. Human disease models in Drosophila melanogaster and the role of the fly in therapeutic drug discovery. Pharmacol. Rev 63:411–36. doi:10.1124/pr.110.003293.
   PubMed Web of Science ®Google Scholar
• Pedrosa, E. C. G. A., A. P. C. Bezerra, I. M. Costa, F. I. Pinheiro, and F. P. Guzen. 2020. Neuroprotective profile of Piper Methysticum (Kava Kava) and its effects on the central nervous system: A systematic review. J. Pharmacol. Chem. Biol. Sci 2:55–84. doi:10.36619/jpcbs.2020.2.56.80.
   Google Scholar
• Perdomo, R. T., C. P. Defende, P. S. Mirowski, T. V. Freire, S. S. Weber, W. S. Garcez, Z. R. Guterres, M. F. C. Matos, and F. R. Garcez. 2020. Myricitrin from Combretum lanceolatum exhibits inhibitory effect on DNA-topoisomerase type IIα and protective effect against in vivo doxorubicin-induced mutagenicity. J. Med. Food 24:273–81. doi:10.1089/jmf.2020.0033.
   PubMedGoogle Scholar
• Prinsloo, D., S. V. Dyk, A. Petzer, and J. P. Petzer. 2019. Monoamine oxidase inhibition by kavalactones from kava (Piper Methysticum). Planta Med. 85:1136–42. doi:10.1055/a-1008-9491.
   PubMed Web of Science ®Google Scholar
• Santana, S. L., C. J. Verçosa, I. F. A. Castro, É. M. Amorim, A. S. Silva, T. M. R. Bastos, L. J. S. Neto, T. O. Santos, E. J. França, and C. Rohde. 2018. Drosophila melanogaster as model organism for monitoring and analyzing genotoxicity associated with city air pollution. Environ. Sci. Pollut. Res 25:32409–17. doi:10.1007/s11356-018-3186-5.
   PubMed Web of Science ®Google Scholar
• Shaik, A. A., D. L. Hermanson, and C. Xing. 2009. Identification of methysticin as a potent and non-toxic NF-κB inhibitor from kava, potentially responsible for kava’s chemopreventive activity. Bioorg. Med. Chem. Lett 19:5732–36. doi:10.1016/j.bmcl.2009.08.003.
   PubMed Web of Science ®Google Scholar
• Sharma, V., R. Madaan, R. Bala, A. Goyal, and R. K. Sindhu. 2021. Pharmacodynamic and pharmacokinetic interactions of herbs with prescribed drugs: A review. Plant Arch 21:185–98. doi:10.51470/PLANTARCHIVES.2021.v21.S1.033.
   Google Scholar
• Showman, A. F., J. D. Baker, C. Linares, K. C. Naeole, R. Borris, E. Johnston, J. Konanui, and H. Turner. 2015. Contemporary Pacific and Western perspectives on `awa (Piper methysticum) toxicology. Fitoterapia 100:56–67. doi:10.1016/j.fitote.2014.11.012.
   PubMed Web of Science ®Google Scholar
• Siddique, H. R., D. K. Chowdhuri, D. K. Saxena, and A. Dhawan. 2005. Validation of Drosophila melanogaster as an in vivo model for genotoxicity assessment using modified alkaline comet assay. Mutagenesis 20:285–90. doi:10.1093/mutage/gei032.
   PubMed Web of Science ®Google Scholar
• Singh, S. P., O. Huck, N. G. Abraham, and S. Amar. 2018. Kavain reduces Porphyromonas gingivalis–induced adipocyte inflammation: Role of PGC-1α signaling. J. Immunol 201:1491–99. doi:10.4049/jimmunol.1800321.
   PubMed Web of Science ®Google Scholar
• Smith, K. K., H. R. W. Dharmaratne, M. W. Feltenstein, S. L. Broom, J. T. Roach, N. P. D. Nanayakkara, I. A. Khan, and K. J. Sufka. 2001. Anxiolytic effects of kava extract and kavalactones in the chick social separation-stress paradigm. Psychopharmacology 155:86–90. doi:10.1007/s002130100686..
   PubMed Web of Science ®Google Scholar
• Tacar, O., P. Sriamornsak, and C. R. Dass. 2012. Doxorubicin: An update on anticancer molecular action, toxicity and novel drug delivery systems. J. Pharm. Pharmacol 65:157–70. doi:10.1111/j.2042-7158.2012.01567.x.
   PubMed Web of Science ®Google Scholar
• Tang, X., and S. Amar. 2016. Kavain inhibition of LPS-induced TNF-α via ERK/LITAF. Toxicol. Res 5:188–96. doi:10.1039/c5tx00164a.
   Web of Science ®Google Scholar
• Tarbah, F., H. Mahler, B. Kardel, W. Weinmann, D. Hafner, and T. H. Daldrup. 2003. Kinetics of kavain and its metabolites after oral application. J. Chromatogr. B Anal. Technol. Biomed. Life Sci 789:115–30. doi:10.1016/s1570-0232(03)00046-1.
   PubMed Web of Science ®Google Scholar
• Tarbah, F. A., H. Mahler, O. Temme, and T. Daldrup. 2000. Mass spectral characterisation of hepatic cell metabolites of D,L-kavain using HPLC and GC/MS systems. Probl. Forensic Sci 42:173–80.
   Google Scholar
• Teschke, R., J. Sarris, and V. Lebot. 2011. Kava hepatotoxicity solution: A six-point plan for new kava standardization. Phytomedicine 18:96–103. doi:10.1016/j.phymed.2010.10.002.
   PubMed Web of Science ®Google Scholar
• Teschke, R., and V. Lebot. 2011. Proposal for a kava quality standardization code. Food Chem. Toxicol 49:2503–16. doi:10.1016/j.fct.2011.06.075.
   PubMed Web of Science ®Google Scholar
• Thomsen, M., and M. Schmidt. 2021. Health policy versus Kava (Piper methysticum): Anxiolytic efficacy may be instrumental in restoring the reputation of a major South Pacific crop. J.Ethnopharmacol268: 113582. doi:10.1016/j.jep.2020.113582.
   PubMed Web of Science ®Google Scholar
• Unger, M., U. Holzgrabe, W. Jacobsen, C. Cummins, and L. Z. Benet. 2002. Inhibition of Cytochrome P450 3A4 by extracts and kavalactones of Piper methysticum (Kava-Kava). Planta Med. 68:1055–58. doi:10.1055/s-2002-36360.
   PubMed Web of Science ®Google Scholar
• Upadhyay, A., E. Tuenter, R. Ahmad, A. Amin, V. Exarchou, S. Apers, N. Hermans, and L. Pieters. 2014. Kavalactones, A novel class of protein glycation and lipid peroxidation inhibitors. Planta Med. 80:1001–08. doi:10.1055/s-0034-1382949.
   PubMed Web of Science ®Google Scholar
• Vasconcelos, M. A., P. C. Orsolin, V. C. Oliveira, P. M. A. P. Lima, M. P. C. Naves, C. R. Morais, N. Nicolau-Júnior, A. M. Bonetti, and M. A. Spano. 2020. Modulating effect of vitamin D3 on the mutagenicity and carcinogenicity of doxorubicin in Drosophila melanogaster and in silico studies. Food Chem. Toxicol 143:111549. doi:10.1016/j.fct.2020.111549.
   PubMed Web of Science ®Google Scholar
• Venancio, V. P., M. C. Marques, M. R. Almeida, L. R. B. Mariutti, C. C. O. Souza, F. Barbosa, M. L. P. Bianchi Jr, C. M. Marzocchi, A. Z. Machado, Antunes, et al.. 2016. Chrysobalanus icaco L. fruits inhibit NADPH oxidase complex and protect DNA against doxorubicin-induced damage in Wistar male rats. J. Toxicol. Environ. Health A 79:885–93. doi:10.1080/15287394.2016.1193454.
   PubMed Web of Science ®Google Scholar
• Véras, J. H., C. R. Do Vale, D. C. S. Lima, M. M. dos Anjos, A. Bernardes, A. V. de Moraes Filho, C. R. Silva, G. R. de Oliveira, C. N. Pérez, and L. Chen-Chen. 2020. Modulating effect of a hydroxychalcone and a novel coumarin–chalcone hybrid against mitomycin-induced genotoxicity in somatic cells of Drosophila melanogaster. Drug Chem. Toxicol. doi:10.1080/01480545.2020.1776314.
   Web of Science ®Google Scholar
• Wang, P., J. Zhu, A. I. Shehu, J. Lu, J. Chen, X. Zhong, and X. Ma. 2019. Enzymes and pathways of kavain bioactivation and biotransformation. Chem. Res. Toxicol 32:1335–42. doi:10.1021/acs.chemrestox.9b00098.
   PubMed Web of Science ®Google Scholar
• Wruck, C. J., M. E. Gotz, T. Herdegen, D. Varoga, L. O. Brandenburg, and T. Pufe. 2008. Kavalactones protect neural cells against amyloid peptide-induced neurotoxicity via extracellular signal-regulated kinase 1/2-dependent nuclear factor erythroid 2-related factor 2 activation. Mol. Pharmacol 73:1785–95. doi:10.1124/mol.107.042499.
   PubMed Web of Science ®Google Scholar
• Yiannis, C., K. Huang, A. N. Tran, C. Zeng, E. Dao, O. Baselyous, M. A. Mithwani, R. Paolini, N. Cirillo, T. Yap, et al.. 2020. Protective effect of kava constituents in an in vitro model of oral mucositis. J. Cancer Res. Clin. Oncol 146:801–11. doi:10.1007/s00432-020-03253-3.
   PubMed Web of Science ®Google Scholar
• Zi, X., and A. R. Simoneau. 2005. Flavokawain A, a novel chalcone from kava extract, induces apoptosis in bladder cancer cells by involvement of Bax protein-dependent and mitochondria-dependent apoptotic pathway and suppresses tumor growth in mice. Cancer Res. 65:3479–86. doi:10.1158/0008-5472.can-04-3803.
   PubMed Web of Science ®Google Scholar
• Zou, L., G. L. Henderson, M. R. Harkey, Y. Sakai, and A. Li. 2004. Effects of kava (Kava-kava, ’Awa, Yaqona, Piper methysticum) on c-DNA-expressed cytochrome P450 enzymes and human cryopreserved hepatocytes. Phytomedicine 11:285–94. doi:10.1078/0944711041495263.
   PubMed Web of Science ®Google Scholar